Michael Edwards

Michael Edwards is Director of Regulatory Affairs, Medpace, with 25 years professional experience acquired within the medical devices and pharmaceutical sector. He has held various senior management positions with high-profile, international organisations, primarily in Regulatory Affairs & Quality Management.

  • Harmonising-HERO

    Harmonising regulation of medicinal allergen products throughout the European Union – the historic situation and subsequent CMDh guidance


    Allergen products in the EU are defined as goods ‘intended to identify or induce a specific acquired alteration in the immunological response to an allergizing agent’. Historically, allergens were authorised under the national frameworks of member states (MS) with some legislation pre-dating the Treaty of Rome in 1957. This led to regulatory problems, such as pharmacovigilance monitoring standards. The Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) addressed these authorisation issues and published a document on recommendations to common regulatory approaches for medicinal allergen products. This article provides an overview of the CMDh guidance, including a summary of some of the responses received during its consultation phase.